4.7 Review

Epigenetic regulation and targeting of ECM for cancer therapy

Journal

AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
Volume 322, Issue 4, Pages C762-C768

Publisher

AMER PHYSIOLOGICAL SOC
DOI: 10.1152/ajpcell.00022.2022

Keywords

ECM; epigenetics; fibrous; TME; therapy

Funding

  1. National Institutes of Health [R03CA230815, R03CA248913, R01CA233481-01A1]

Ask authors/readers for more resources

This mini review discusses epigenetic modifications that regulate the expression of fibrous ECM proteins and glycoproteins and explores the prospects of targeting them for cancer therapy.
The tumor microenvironment (TME) composed of different types of cells embedded in extracellular matrix (ECM) has crucial effects on cancer growth and metastasis. ECM is made of a variety of proteins that provide structural support to the cells and regulate biological functions by modulating the cross talk among cells, thus effecting tumor growth and progression. In this mini review, the author discusses epigenetic modifications that regulate the expression of fibrous ECM proteins and glycoproteins and the prospects of targeting them for cancer therapy.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available